- Progesterone 1.5% transdermal cream
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Progesterone 1.5% transdermal cream | Start Date 03-10-2023 | End Date |
Previous Name | Previous Name Progesterone 1.5% cream | Start Date 16-04-2010 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Transdermal
- Form
- Transdermal cream
- Ontology Form/Route
- cream.transdermal
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- G03DA04
- BNF Codes
-
- BNF code 13150000
Code | Start Date | End Date |
---|---|---|
17156111000001101 | 16-04-2010 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Progesterone | Based on Ingredient Substance | 15 mg | 1 gram |
Name
Progesterone
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
15
Strength and UOM (Dmr)
1
Parent Products
-
VTMProgesterone
-
VMP(Current) Progesterone 1.5% transdermal cream
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
60 gram |